All Reports

The global RNAi therapeutics market is expected to record a value of US$1.26 billion in 2028, progressing at a CAGR of 10.02%, over the period 2024-2028. Factors such as rising utilization in oncology pharmaceuticals, accelerating growth rates of infectious diseases, enlarging geriatric population, increasing prevalence of neurodegenerative disorders and progress in collaborations and associate ..

The US health expenditure is forecasted to reach US$6.41 trillion in 2028, experiencing growth at a CAGR of 5.62% during the period spanning from 2024 to 2028. The national health expenditure by source of funds can be segmented as follows: Managed care, Out of pocket, Investments and Others. In 2023, the dominant share was held by managed care segment. This was being followed by out of pocket, ..

The global plasma derived therapy market is anticipated to reach US$58.26 billion in 2028, growing at a CAGR of 7.20% during the period spanning 2024-2028. The growth in the market has been driven by factors like rising geriatric population, increasing prevalence of genetic disorders, government initiatives, rising demand for albumin, escalating use of plasma proteins in pharmaceuticals, increa ..

The global animal health market is expected to record a value of US$64.71 billion in 2028, growing at a CAGR of 6.31% for the period spanning 2024-2028. The factors such as growing middle class population, rising cattle/cow population, surge in demand for animal protein, rising U.S. expenditure on pets and growing  urbanization would drive the growth of the market. However, the market grow ..

The China biological reagent market is forecasted to reach US$8.45 billion in 2028, experiencing growth at a CAGR of 14.95% during the period spanning from 2024 to 2028. Growth in the China biological reagent market was supported by factors such as increasing research in the field of life sciences, technological innovations, rising number of genome projects, rising incidence of genetic disorder ..

The global point of care diagnostics market is anticipated to reach US$43.10 billion in 2028, growing at a CAGR of 6.60% during the period spanning 2024-2028. The growth in the market has been driven by factors like rising global healthcare expenditure, rising geriatric population, escalating stress issues, increasing prevalence of chronic and infectious diseases, rising utilization of novel im ..

The global interventional pulmonology market is forecasted to reach US$5.24 billion in 2028, rising at a CAGR of 5.81%, for the time period of 2024-2028. Factors such as growing incidence of lung cancer, rising CO2 emission, expansion of medical device industry, surging COPD mortality rate, increasing elderly population and increasing public awareness would drive the growth of the market. Howev ..

The global dental implants market is expected to record a value of US$6.48 billion in 2028, rising at a CAGR of 6.38%, for the time period of 2024-2028. Factors such as increasing geriatric population, growing concern for oral healthcare, expansion of dental service organizations, rising preference for cosmetic dentistry and surging focus on edentulous treatment would drive the growth of the ma ..

European medical diagnostics market is expected to reach US$109.91 billion in 2028, growing at a CAGR of 5.69%, for the time period of 2024-2028. Factors such as rise in number of new cancer cases, expansion of medical device industry, growth in geriatric population, accelerating demand for In-Vitro Diagnostic (IVD) and rapid urbanization would drive the growth of the market. However the market ..

The global hemophilia market is anticipated to reach US$17.76 billion in 2028, growing at a CAGR of 5.81% during the period spanning 2024-2028. The growth in the market has been driven by factors like increasing healthcare expenditure, surging identified hemophilia patient volume, increased focus on prophylactic treatment, rise in male population and favorable government initiatives. The market ..